David joined Clifford Swan in 2025 as an Equity Research Analyst to conduct fundamental equity research, primarily on high-quality mid- to large-capitalized companies and to explore international equity opportunities. He has a strong buy-side background, most recently spending over four years in equity research at Invesco in Texas where he focused on smaller, growing international companies and large domestic companies. Prior to that, he served as a Research Associate at Harris Associates in Chicago after starting his investment career at Raymond James authoring broker research covering the biotechnology and specialty pharmaceutical industries.

Outside of the office, David is an avid Philadelphia sports fan. He and his wife enjoy staying active with their two dogs and traveling. Their favorite destinations so far include Hawaii and Portugal, with highly anticipated upcoming trips to Bali and Japan.